|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 78.94 USD | +1.13% |
|
-11.86% | +2.78% |
| 07-07 | RBC Capital Adjusts PTC Therapeutics Price Target to $85 From $82, Maintains Sector Perform Rating | MT |
| 06-29 | PTC Therapeutics, Inc.(NasdaqGS:PTCT) added to Russell 2000 Value-Defensive Index | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Neutral |
| Resistance | 89.55 | 89.55 | 85.99 |
| Spread/Res. | -12.82% | -12.82% | -9.21% |
| Spread/Supp. | +1.59% | +6.55% | +72.04% |
| Support | 76.85 | 73.27 | 45.38 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- PTCT Stock
- Charts PTC Therapeutics, Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
